Interleaving Stimulation Improves Dyskinesia in Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

February 28, 2025

Conditions
Parkinson's Disease
Interventions
DEVICE

interleaving stimulation

ILS consists of two rapid and alternate stimulation programs with different contacts, amplitudes, and pulse width but the same frequency up to a maximum of 125Hz. Contact selection is determined by postoperative stereotactic computed tomography and clinical evaluation to achieve a balance between motor improvement and tolerable side effects. For example, ILS is successfully applied for PD motor symptoms (stimulation of subthalamic nucleus) as well as dyskinesia (additional stimulation of zona incerta).

DEVICE

empirical stimulation

Patients are settled with simple polar stimulation with combined parameters adjustment (monopolar mode, 60\~90µs pulse width, 130\~185Hz frequency and varied voltage) during the follow-up.

Trial Locations (1)

200040

RECRUITING

Huashan Hospital, Shanghai

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Huashan Hospital

OTHER